FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206920003> ?p ?o ?g. }

• W4206920003 endingPage "247" @default.
• W4206920003 startingPage "247" @default.
• W4206920003 abstract "Nanomedicine plays an essential role in developing new therapies through novel drug delivery systems, diagnostic and imaging systems, vaccine development, antibacterial tools, and high-throughput screening. One of the most promising drug delivery systems are nanoparticles, which can be designed with various compositions, sizes, shapes, and surface modifications. These nanosystems have improved therapeutic profiles, increased bioavailability, and reduced the toxicity of the product they carry. However, the clinical translation of nanomedicines requires a thorough understanding of their properties to avoid problems with the most questioned aspect of nanosystems: safety. The particular physicochemical properties of nano-drugs lead to the need for additional safety, quality, and efficacy testing. Consequently, challenges arise during the physicochemical characterization, the production process, in vitro characterization, in vivo characterization, and the clinical stages of development of these biopharmaceuticals. The lack of a specific regulatory framework for nanoformulations has caused significant gaps in the requirements needed to be successful during their approval, especially with tests that demonstrate their safety and efficacy. Researchers face many difficulties in establishing evidence to extrapolate results from one level of development to another, for example, from an in vitro demonstration phase to an in vivo demonstration phase. Additional guidance is required to cover the particularities of this type of product, as some challenges in the regulatory framework do not allow for an accurate assessment of NPs with sufficient evidence of clinical success. This work aims to identify current regulatory issues during the implementation of nanoparticle assays and describe the major challenges that researchers have faced when exposing a new formulation. We further reflect on the current regulatory standards required for the approval of these biopharmaceuticals and the requirements demanded by the regulatory agencies. Our work will provide helpful information to improve the success of nanomedicines by compiling the challenges described in the literature that support the development of this novel encapsulation system. We propose a step-by-step approach through the different stages of the development of nanoformulations, from their design to the clinical stage, exemplifying the different challenges and the measures taken by the regulatory agencies to respond to these challenges." @default.
• W4206920003 created "2022-01-26" @default.
• W4206920003 creator A5004434870 @default.
• W4206920003 creator A5013252020 @default.
• W4206920003 creator A5015958096 @default.
• W4206920003 creator A5027788373 @default.
• W4206920003 creator A5034924392 @default.
• W4206920003 creator A5059569580 @default.
• W4206920003 creator A5078603496 @default.
• W4206920003 date "2022-01-21" @default.
• W4206920003 modified "2023-10-14" @default.
• W4206920003 title "The Hitchhiker’s Guide to Human Therapeutic Nanoparticle Development" @default.
• W4206920003 cites W1088146625 @default.
• W4206920003 cites W1579782115 @default.
• W4206920003 cites W1698993839 @default.
• W4206920003 cites W1870080799 @default.
• W4206920003 cites W1873573341 @default.
• W4206920003 cites W1953453110 @default.
• W4206920003 cites W1963515338 @default.
• W4206920003 cites W1965063429 @default.
• W4206920003 cites W1969018013 @default.
• W4206920003 cites W1982387635 @default.
• W4206920003 cites W1985686789 @default.
• W4206920003 cites W1989230986 @default.
• W4206920003 cites W1990424094 @default.
• W4206920003 cites W2005066650 @default.
• W4206920003 cites W2011582528 @default.
• W4206920003 cites W2013602323 @default.
• W4206920003 cites W2027142859 @default.
• W4206920003 cites W2038163024 @default.
• W4206920003 cites W2041870189 @default.
• W4206920003 cites W2052918638 @default.
• W4206920003 cites W2054745605 @default.
• W4206920003 cites W2056543113 @default.
• W4206920003 cites W2059280265 @default.
• W4206920003 cites W2059503044 @default.
• W4206920003 cites W2070719925 @default.
• W4206920003 cites W2071215562 @default.
• W4206920003 cites W2074594119 @default.
• W4206920003 cites W2078628247 @default.
• W4206920003 cites W2086943108 @default.
• W4206920003 cites W2092856965 @default.
• W4206920003 cites W2097622107 @default.
• W4206920003 cites W2118398430 @default.
• W4206920003 cites W2121818758 @default.
• W4206920003 cites W2128858080 @default.
• W4206920003 cites W2135913252 @default.
• W4206920003 cites W2140174085 @default.
• W4206920003 cites W2140720810 @default.
• W4206920003 cites W2146798024 @default.
• W4206920003 cites W2147262562 @default.
• W4206920003 cites W2153443548 @default.
• W4206920003 cites W2168223217 @default.
• W4206920003 cites W2195616206 @default.
• W4206920003 cites W2212777275 @default.
• W4206920003 cites W2220048569 @default.
• W4206920003 cites W2222530813 @default.
• W4206920003 cites W2258166908 @default.
• W4206920003 cites W2268101927 @default.
• W4206920003 cites W2270059651 @default.
• W4206920003 cites W2282102978 @default.
• W4206920003 cites W2285408387 @default.
• W4206920003 cites W2311458833 @default.
• W4206920003 cites W2320866708 @default.
• W4206920003 cites W2340662778 @default.
• W4206920003 cites W2343876031 @default.
• W4206920003 cites W2344850880 @default.
• W4206920003 cites W2346835738 @default.
• W4206920003 cites W2387045967 @default.
• W4206920003 cites W2414230095 @default.
• W4206920003 cites W2421275313 @default.
• W4206920003 cites W2425489930 @default.
• W4206920003 cites W2472550594 @default.
• W4206920003 cites W2480332792 @default.
• W4206920003 cites W2498896723 @default.
• W4206920003 cites W2499212209 @default.
• W4206920003 cites W2509242802 @default.
• W4206920003 cites W2510046850 @default.
• W4206920003 cites W2512140959 @default.
• W4206920003 cites W2518588461 @default.
• W4206920003 cites W2519678626 @default.
• W4206920003 cites W2520197417 @default.
• W4206920003 cites W2524334680 @default.
• W4206920003 cites W2548482006 @default.
• W4206920003 cites W2555048663 @default.
• W4206920003 cites W2556797199 @default.
• W4206920003 cites W2560056856 @default.
• W4206920003 cites W2561796759 @default.
• W4206920003 cites W2563008081 @default.
• W4206920003 cites W2574256996 @default.
• W4206920003 cites W2579221874 @default.
• W4206920003 cites W2582035559 @default.
• W4206920003 cites W2586072945 @default.
• W4206920003 cites W2586783706 @default.
• W4206920003 cites W2586966691 @default.
• W4206920003 cites W2587710699 @default.
• W4206920003 cites W2590900400 @default.
• W4206920003 cites W2594191206 @default.

• next